Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/11/2019
China's Cancer Patients Hit by New Law on Experimental Drug Treatments...
12/11/2019
Harbin Pharmaceutical Group Poised to Take Over Ailing GNC
12/11/2019
Private Investigator Couple Sue GSK for Misleading Work in China
12/10/2019
National Drug Usage Monitoring Platform Becomes Operational
12/10/2019
SAMR Solicits Public Comments on the Provisions for Registration of Dr...
12/10/2019
CStone's anti-PD-L1 antibody Demonstrates Promising Antitumor Activity
12/10/2019
China Cuts Prices For 70 More Drugs After Talks with Pharmaceutical Fi...
12/9/2019
PingAn Good Doctor and Merck Sign Agreement to Explore Integrated Heal...
12/9/2019
Samsung Bioepis Approved to Initiate Phase 3 Trial of Trastuzumab Bios...
12/9/2019
Joinn Bio Raises $60M in Round A Financing
12/6/2019
NHSA Issues New Policy for Drug Price Regulation
12/6/2019
Recent Executive Moves
12/6/2019
Innovent Announces First Patient Dosed in Phase I Trial of Anti-LAG-3 ...
12/5/2019
Amgen's IND for Osteoporosis Drug Romosozumab Approved in China
12/5/2019
XiAn Janssen's Application for 2nd Indication of Erleada Accepted in C...
12/5/2019
Interpace Bio Expands Strategic Partnership with Genecast in China
12/5/2019
AstraZeneca-Merck Lynparza Approved in China for Ovarian Cancer
12/4/2019
Bio-Thera's IND for Biosimilar of Stelara (Ustekinumab) Approved in Ch...
12/4/2019
Yaobili Set to Change China's Pharmaceutical Industry with New Model
12/4/2019
Additional Indication for Lenvima (Lenvatinib) For Differentiated Thyr...
12/3/2019
Why Chinese Biotech Companies Are Not For Faint-Hearted Investors
12/3/2019
New Round of Negotiation for NRDL Access Begins as Big Pharma Bosses L...
12/3/2019
NHC Sets Six Major New Goals to Keep AIDS/AIDS Under Control
12/3/2019
Biotech Startup Alphamab to Raise $230M in HK IPO
12/3/2019
EOC Pharma Raised $71M in Series C Round
12/3/2019
GI Innovation Out-licenses Immunotherapy Drug Candidate to Simcere Pha...
12/3/2019
China Gives Merck, BMS Cold Shoulder on Reimbursement List as PD-1 Bat...
12/2/2019
Expanded 4+7 Trial to Add 35 More Drug Products for National Level Pur...
12/2/2019
State Council Issues New Centralized Drug Procurement Purchase and Use...
12/2/2019
NMPA Announces Withdrawal of Additional 68 Certificate Requirements to...
Page:
201
/
720
Total number of articles:
21572
:
[First]
[<<]
[199]
[200]
[201]
[202]
[203]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit